Loading clinical trials...
Loading clinical trials...
Multicenter Prospective Evaluation of the Efficacy of a Self-Assembling Matrix Forming Gel to Prevent Stricture Formation in High-Risk Patients
Conditions
Interventions
Purastat SAP gel application
Locations
6
United States
AdventHealth Orlando
Orlando, Florida, United States
Parkview
Fort Wayne, Indiana, United States
Johns Hopkins
Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Columbia University Irving Medical Center
New York, New York, United States
Baylor St. Lukes
Houston, Texas, United States
Start Date
September 19, 2022
Primary Completion Date
January 23, 2025
Completion Date
January 23, 2025
Last Updated
January 24, 2025
NCT07407491
NCT06795074
NCT05383274
NCT05561127
NCT06655051
NCT06697106
Lead Sponsor
AdventHealth
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions